MGRXNasdaq

Mangoceuticals Inc.

Healthcare·Reproductive·Dallas, TX, United States
Reproductive

Mangoceuticals Inc. (MGRX): 1 pipeline candidate · ~0 mo cash runway. Updated within the last hour.

4.4/10

BioSniper Score

3-factor signal · derived from public data

Cash Runway0.1

0.4 months

Financial Health9.9

D/E 0.07 · 0% dilution

Pipeline MaturityN/A

N/A

Pipeline Breadth3.3

1 candidate

Catalyst MomentumN/A

N/A

Insider SignalN/A

N/A

A transparent, data-derived signal for Mangoceuticals Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$6.2M

Cash

$175K

Quarterly Burn

$1.3M

Runway

0.4 mo

Revenue

$68K

Cash Runway vs Catalysts

Tracked catalysts land within the current projected cash runway.

Cash ends ~Jun 2026
Today~7 mo out
Catalyst within runway

Pipeline (1 candidate)

DrugPhase
mango ed

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

15

Total value held

$258K

HolderSharesValue
vanguard capital management llc246,082$89K
geode capital management, llc194,482$70K
jane street group, llc72,746$26K
vanguard fiduciary trust co57,163$21K
boothbay fund management, llc38,441$14K
northern trust corp37,579$14K
stonex group inc.16,039$6K
xtx topco ltd13,142$5K
sunbelt securities, inc.12,000$4K
goldman sachs group inc11,757$4K

Showing top 10 of 15 institutional holders of Mangoceuticals Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.

·CEO: Mr. Jacob D. Cohen

Frequently asked questions

How many drug candidates are in Mangoceuticals Inc.'s pipeline?

Mangoceuticals Inc. (MGRX) has 1 pipeline candidate tracked by BioSniper across SEC filings and clinical trial registrations.

What is Mangoceuticals Inc.'s cash runway?

Based on its most recent reported cash balance and quarterly burn rate, Mangoceuticals Inc. has approximately 0.4 months of cash runway.

What is Mangoceuticals Inc.'s market capitalization?

Mangoceuticals Inc.'s market capitalization is approximately $6.2M.

Who is the CEO of Mangoceuticals Inc.?

Mr. Jacob D. Cohen is the chief executive officer of Mangoceuticals Inc. (MGRX).

Get the full picture on Mangoceuticals Inc.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.